000 04034naa a22006377i 4500
001 UMUN-OA-20261005-MLS-035
003 local
005 20261005174904.0
006 m o d
007 cr||||||||||||
008 261005s2018 xx o u000 0 eng d
024 7 _a10.1186/s12936-018-2201-0
_2doi
035 _a(local)EuropePMC:PMC5789620
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aMaria Gruenberg
_eauthor.
245 1 0 _aPlasmodium vivax molecular diagnostics in community surveys: pitfalls and solutions. /
_cMaria Gruenberg; Clara Antunes Moniz; Natalie Ellen Hofmann [and others].
264 1 _a[Place of publication not identified] :
_bBMC,
_c2018.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aA distinctive feature of Plasmodium vivax infections is the overall low parasite density in peripheral blood. Thus, identifying asymptomatic infected individuals in endemic communities requires diagnostic tests with high sensitivity. The detection limits of molecular diagnostic tests are primarily defined by the volume of blood analysed and by the copy number of the amplified molecular marker serving as the template for amplification. By using mitochondrial DNA as the multi-copy template, the detection limit can be improved more than tenfold, compared to standard 18S rRNA targets, thereby allowing detection of lower parasite densities. In a very low transmission area in Brazil, application of a mitochondrial DNA-based assay increased prevalence from 4.9 to 6.5%. The usefulness of molecular tests in malaria epidemiological studies is widely recognized, especially when precise prevalence rates are desired. Of concern, however, is the challenge of demonstrating test accuracy and quality control for samples with very low parasite densities. In this case, chance effects in template distribution around the detection limit constrain reproducibility. Rigorous assessment of false positive and false negative test results is, therefore, required to prevent over- or under-estimation of parasite prevalence in epidemiological studies or when monitoring interventions.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aMitochondrial DNA
650 4 _aSurveillance
650 4 _aPlasmodium vivax
650 4 _aQuantification
650 4 _aLAMP
650 4 _aMolecular Diagnostics
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _amolecular diagnostics
655 4 _aReview articles.
700 0 _aClara Antunes Moniz
_eauthor.
700 0 _aNatalie Ellen Hofmann
_eauthor.
700 0 _aRahel Wampfler
_eauthor.
700 0 _aCristian Koepfli
_eauthor.
700 0 _aIvo Mueller
_eauthor.
700 0 _aWuelton Marcelo Monteiro
_eauthor.
700 0 _aMarcus Lacerda
_eauthor.
700 0 _aGisely Cardoso de Melo
_eauthor.
700 0 _aAndrea Kuehn
_eauthor.
700 0 _aAndre M Siqueira
_eauthor.
700 0 _aIngrid Felger
_eauthor.
773 0 _tMalaria journal
_gVol. 17, no. 1, (2018), pages/article 55
_x1475-2875
856 4 0 _uhttps://europepmc.org/articles/PMC5789620
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC5789620
_qlocal
942 _n0
999 _c1177
_d1177